E066 Baseline characteristics of patients initiating ixekizumab, secukinumab or a tumour necrosis factor inhibitor by country in the 24-month Prospective Psoriatic Arthritis Observational Study of Persistence of Treatment - PRO-SPIRIT

Nicola Gullick; Mohamed Sheesh; Cedric Laedermann; Marcus Ngantcha; Beatrice Gittens; Khai Jing Ng; William Tillett; Jacques Morel; Ennio Lubrano; Rieke Alten; Lars Erik Kristensen; Vinod Chandran; Angels Martinez-Ferrer; Bruce Kirkham

doi:10.1093/rheumatology/keae163.293

Retour

E066 Baseline characteristics of patients initiating ixekizumab, secukinumab or a tumour necrosis factor inhibitor by country in the 24-month Prospective Psoriatic Arthritis Observational Study of Persistence of Treatment - PRO-SPIRIT

Article de revue

Avec comité de lecture

E066 Baseline characteristics of patients initiating ixekizumab, secukinumab or a tumour necrosis factor inhibitor by country in the 24-month Prospective Psoriatic Arthritis Observational Study of Persistence of Treatment - PRO-SPIRIT

Nicola Gullick, Mohamed Sheesh, Cedric Laedermann, Marcus Ngantcha, Beatrice Gittens, Khai Jing Ng, William Tillett, Jacques Morel, Ennio Lubrano, Rieke Alten, …

Rheumatology (Oxford, England), Vol.63(Supplement_1)

24/04/2024

DOI: https://doi.org/10.1093/rheumatology/keae163.293

Indicateurs

1 Consultations de la notice

Détails

Titre: E066 Baseline characteristics of patients initiating ixekizumab, secukinumab or a tumour necrosis factor inhibitor by country in the 24-month Prospective Psoriatic Arthritis Observational Study of Persistence of Treatment - PRO-SPIRIT
Créateurs - sans rôle: Nicola Gullick
Mohamed Sheesh
Cedric Laedermann
Marcus Ngantcha
Beatrice Gittens
Khai Jing Ng
William Tillett
Jacques Morel
Ennio Lubrano
Rieke Alten
Lars Erik Kristensen
Vinod Chandran
Angels Martinez-Ferrer
Bruce Kirkham
Détails de publication: Rheumatology (Oxford, England), Vol.63(Supplement_1)
Identifiants: 99148839309311
Unité académique: Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExp
Langue: English
Type de ressource: Journal article